Underlying revenue growth +9.1%, Underlying Core EPS +54.2%
OSAKA, Japan - Friday, July 29th 2016 [ME NewsWire]
(BUSINESS WIRE)-- Takeda Pharmaceutical Company Limited (TOKYO:4502):
Strong first quarter results and confidence in Management Guidance
•
Underlying revenue grew +9.1%, driven by a +15.3% increase of Takeda's Growth Drivers (GI, Oncology, CNS and Emerging Markets). (Reported revenue declined -2.8% to 434.0 billion yen, due to divestments and currency impacts)
•
Underlying Core Earnings advanced +40.4% (reported operating profit was 152.9 billion yen, up from 49.6 billion yen in Q1, 2015)
•
Underlying Core Net Profit and EPS were up +54.2% (reported EPS increased to 127 yen, from 31 yen in Q1, 2015)
&
...
Read more »